Home
Browse
Search
Statistics
About
Usage
PMID: 20638569
Goetzinger KR, Cahill AG
An update on cystic fibrosis screening.
Clin Lab Med. 2010 Sep;30(3):533-43.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
12
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:12:238
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 20638569:12:189
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 20638569:12:182
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 20638569:12:197
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 20638569:12:175
status:
NEW
view ABCC7 p.Gly542* details
The DF508 mutation causes a protein misfold that inhibits migration of the CFTR protein from the endoplasmic reticulum to the cell membrane.1,7 Other common mutations include
G542X
,
R553X
,
W1282X
,
N1303K
, 62111 G-to-T, 1717-1 G-to-A, and
R117H
.8 These result in a spectrum of protein dysfunction ranging from the production of unstable RNA to CFTR cell surface instability.7 PHENOTYPIC VARIATION IN CFTR MUTATIONS Although 70% of CF patients are either homozygotes or compound heterozygotes for these 8 common mutations, there is tremendous variation in their phenotype.
Login to comment
14
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:14:15
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 20638569:14:129
status:
NEW
view ABCC7 p.Asn1303Lys details
Alternatively,
R117H
/DF508 compound heterozygotes tend to exhibit pancreatic sufficiency with varying pulmonary manifestations.9
N1303K
has been associated with yet another phenotype: the early onset of pancreatic insufficiency and a wide spectrum of pulmonary disease.10 Experts have hypothesized that there are gene-environment interactions that may explain the variable pulmonary phenotype observed across the spectrum of CFTR genotypes.12,13 For example, in 2008, Collaco and colleagues12 demonstrated that any secondhand tobacco exposure had a negative long-term effect on lung function in CF patients.
Login to comment
15
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:15:234
status:
NEW
view ABCC7 p.Arg117His details
These adverse effects were amplified in the presence of variants in a CF modifier gene, transforming growth factor b1 (TGFb1), thus providing support for gene-environment interactions.14 Another well-studied phenotypic variant is the
R117H
mutation and its association with the 5T/7T/9T polymorphism in intron 8 of the same allele.
Login to comment
16
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:16:0
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:16:46
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:16:382
status:
NEW
view ABCC7 p.Arg117His details
R117H
paired with the 7T variant (in cis) and
R117H
paired with the 5T variant (in trans) have been observed in infertile but otherwise healthy men with congenital bilateral absence of the vas deferens (CBAVD).15,16 When this same mutation is paired with the 5T variant (in cis), signs and symptoms of classical CF are observed.17 This has led to extensive debate as to whether the
R117H
mutation should even be included in the prenatal screening panel Fig. 1.
Login to comment
19
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:19:23
status:
NEW
view ABCC7 p.Arg117His details
Despite this fact, the
R117H
mutation remains a part of the standard prenatal carrier screening panel, with a reflex test for the 5T/7T/9T variant performed if positive for this mutation.
Login to comment
24
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 20638569:24:151
status:
NEW
view ABCC7 p.Trp1282* details
As previously noted, the most common mutation in the Caucasian population is DF508, and the most common mutation in the Ashkenazi Jewish population is
W1282X
followed by DF508.18 Although Hispanics exhibit a relatively high incidence of disease, the sensitivity of carrier testing remains only 57% to 72% because detectable alleles account for only slightly more than half of the CF mutations observed in this population.
Login to comment
32
ABCC7 p.Gly622Asp
X
ABCC7 p.Gly622Asp 20638569:32:83
status:
NEW
view ABCC7 p.Gly622Asp details
ABCC7 p.Gln98Arg
X
ABCC7 p.Gln98Arg 20638569:32:93
status:
NEW
view ABCC7 p.Gln98Arg details
Two additional mutations also not included in the current carrier screening panel,
G622D
and
Q98R
, were incidentally identified.
Login to comment
47
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 20638569:47:48
status:
NEW
view ABCC7 p.Ile148Thr details
Based on this review, 2 mutations (1078delT and
I148T
) were removed from the standard screening panel, narrowing it to include only 23 mutations.
Login to comment
51
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:51:31
status:
NEW
view ABCC7 p.Arg117His details
When a patient is positive for
R117H
, a reflex test for the 5T/7T/9T variant is sent.
Login to comment
52
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:52:96
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:52:151
status:
NEW
view ABCC7 p.Arg117His details
If positive for 5T, determination as to whether the polymorphism is in cis or in trans with the
R117H
allele is undertaken.22 As discussed previously,
R117H
in combination with the 5T variant in trans manifests as CBAVD, but if in cis with the 5T variant, classical CF is expressed.
Login to comment
53
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 20638569:53:146
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 20638569:53:218
status:
NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Ile506Val
X
ABCC7 p.Ile506Val 20638569:53:200
status:
NEW
view ABCC7 p.Ile506Val details
ABCC7 p.Ile507Val
X
ABCC7 p.Ile507Val 20638569:53:207
status:
NEW
view ABCC7 p.Ile507Val details
Given that 5% of the general population will test positive for the 5T polymorphism alone, this test is recommended only as a reflex to a positive
R117H
result.22,23 Non CF-causing variants, including
I506V
,
I507V
, and
F508C
, can mistakenly cause a false-positive result based on laboratory and testing methodologies.
Login to comment
54
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 20638569:54:245
status:
NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 20638569:54:439
status:
NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Ile506Val
X
ABCC7 p.Ile506Val 20638569:54:291
status:
NEW
view ABCC7 p.Ile506Val details
ABCC7 p.Ile506Val
X
ABCC7 p.Ile506Val 20638569:54:421
status:
NEW
view ABCC7 p.Ile506Val details
ABCC7 p.Ile507Val
X
ABCC7 p.Ile507Val 20638569:54:301
status:
NEW
view ABCC7 p.Ile507Val details
ABCC7 p.Ile507Val
X
ABCC7 p.Ile507Val 20638569:54:428
status:
NEW
view ABCC7 p.Ile507Val details
For example, in patients who screen positive for DF508 carrier status and for one of the aforementioned mutations, a false-positive test for DF508 homozygosity may be obtained, although the patient is an otherwise healthy individual.22 Although
F508C
has been associated with CBAVD, neither
I506V
nor
I507V
have been associated with any phenotypic manifestations of classical CF or CBAVD.24 Therefore, reflex testing for
I506V
,
I507V
, and
F508C
should be performed in any healthy individual who tests positive for DF508 or DI507 homozygosity, but these mutations should not be otherwise used for a priori testing.
Login to comment